Viewing Study NCT05130450


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-25 @ 2:59 PM
Study NCT ID: NCT05130450
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2021-11-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)
Sponsor: Ionis Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module